CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-28 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +50,000 | 50,000 | ||
| 2019-01-28 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to buy Common Stock | +184,659 | 184,659 | ||
| 2019-01-28 | RODINO III PETER W. Dir Govt Relations/Sectry | Grant or award · Options to buy Common Stock | +198,864 | 198,864 | ||
| 2019-01-28 | PASCALE ADAM CFO | Grant or award · Options to buy Common Stock | +142,046 | 142,046 | ||
| 2019-01-28 | SPRINGATE WAYNE S Sr. VP of Operations | Grant or award · Options to buy Common Stock | +142,046 | 142,046 | ||
| 2019-01-28 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Grant or award · Options to buy Common Stock | +426,136 | 426,136 | ||
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +1,354 | $0.19 | $256 | 779,661 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +5 | $0.19 | $1 | 779,666 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +9,557 | $0.19 | $2K | 789,223 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +2,400 | $0.19 | $463 | 791,623 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +50 | $0.19 | $10 | 791,673 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +300 | $0.19 | $58 | 791,973 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +334 | $0.19 | $65 | 792,307 |
| 2018-11-30 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +6,000 | $0.20 | $1K | 798,307 |
| 2018-11-27 | MITCHELL WILLIAM M Director | Grant or award | +2,500 | 11,197 | ||
| 2018-11-27 | APPELROUTH STEWART Director | Grant or award | +2,500 | 269,488 | ||
| 2018-11-27 | RODINO III PETER W. Dir Govt Relations/Sectry | Grant or award | +2,500 | 18,373 | ||
| 2018-11-27 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Grant or award | +2,500 | 778,307 | ||
| 2018-11-27 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award | +2,500 | 44,304 | ||
| 2018-11-27 | SPRINGATE WAYNE S Sr. VP of Operations | Grant or award | +2,500 | 67,273 |
Page 13 of 14 · 264 trades